C57BL/6JCya-Suv39h1em1/Cya
Common Name:
Suv39h1-KO
Product ID:
S-KO-20233
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Suv39h1-KO
Strain ID
KOCMP-20937-Suv39h1-B6J-VA
Gene Name
Product ID
S-KO-20233
Gene Alias
DXHXS7466e; H3-K9-HMTase 1; KMT1A; mIS6
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
X
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Suv39h1em1/Cya mice (Catalog S-KO-20233) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000115638
NCBI RefSeq
NM_011514
Target Region
Exon 2~3
Size of Effective Region
~2.5 kb
Detailed Document
Overview of Gene Research
Suv39h1, a lysine methyltransferase, is known for its role in introducing di-and trimethylation at histone H3 lysine 9 (H3K9), which is crucial for maintaining heterochromatin and gene repression. It contains a catalytic SET domain and a chromodomain, and is involved in multiple biological pathways. Genetic models, such as KO/CKO mouse models, have been valuable in studying its functions [7].
In liver fibrosis, HSC-specific or myofibroblast-specific deletion of Suv39h1 in mice ameliorated liver fibrosis. Suv39h1 expression was upregulated during HSC-myofibroblast transition, and its knockdown blocked this transition in vitro. Mechanistically, Suv39h1 bound to the promoter of heme oxygenase 1 (HMOX1) and repressed its transcription [1].
In adoptive T-cell therapies, genetic disruption of SUV39H1 enhanced the early expansion, long-term persistence, and antitumor efficacy of human CAR T cells in leukemia and prostate cancer models. It also optimized the long-term functional persistence of BBz-CAR T cells in solid tumor models, protecting against relapses and rechallenges [2,3].
In limb ischemia of mice, pharmaceutical inhibition or genetic deletion of SUV39H1 improved blood perfusion, capillary density, and angiogenesis in ischemic muscle tissue [4].
In liver ischemia-reperfusion injury, global or hepatocyte conditional Suv39h1 KO mice were protected from the injury [5].
In MLL-AF9-induced acute myeloid leukemia, Suv39h1 overexpression increased leukemia latency and decreased the frequency of LSCs, while knockdown accelerated disease progression [6].
In glioblastoma, knockdown of SUV39H1 in patient-derived GSCs impaired their proliferation and stemness, and targeting SUV39H1 in vivo inhibited GSC-driven tumor formation [8].
In summary, Suv39h1 plays essential roles in multiple biological processes and disease conditions. KO/CKO mouse models have been instrumental in revealing its functions in diseases like liver fibrosis, cancer, limb ischemia, and liver ischemia-reperfusion injury, offering potential therapeutic targets for these conditions.
References:
1. Kong, Ming, Zhou, Junjing, Kang, Aoqi, Xu, Yong, Li, Zilong. 2024. Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis. In Gut, 73, 810-824. doi:10.1136/gutjnl-2023-329671. https://pubmed.ncbi.nlm.nih.gov/38176898/
2. Jain, Nayan, Zhao, Zeguo, Koche, Richard P, Giavridis, Theodoros, Sadelain, Michel. . Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function. In Cancer discovery, 14, 142-157. doi:10.1158/2159-8290.CD-22-1319. https://pubmed.ncbi.nlm.nih.gov/37934007/
3. López-Cobo, Sheila, Fuentealba, Jaime R, Gueguen, Paul, Saitakis, Michael, Amigorena, Sebastian. . SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors. In Cancer discovery, 14, 120-141. doi:10.1158/2159-8290.CD-22-1350. https://pubmed.ncbi.nlm.nih.gov/37934001/
4. Niu, Wenhao, Cao, Wenyue, Wu, Feng, Liang, Chun. . SUV39H1 Inhibits Angiogenesis in Limb Ischemia of Mice. In Cell transplantation, 32, 9636897231198167. doi:10.1177/09636897231198167. https://pubmed.ncbi.nlm.nih.gov/37811706/
5. Li, Zilong, Li, Jichen, Wu, Meng, Qin, Lei, Fan, Zhiwen. 2024. Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injury. In Redox biology, 78, 103414. doi:10.1016/j.redox.2024.103414. https://pubmed.ncbi.nlm.nih.gov/39603205/
6. Chu, Yajing, Chen, Yangpeng, Guo, Huidong, Shi, Jun, Yuan, Weiping. 2020. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia. In Oncogene, 39, 7239-7252. doi:10.1038/s41388-020-01495-6. https://pubmed.ncbi.nlm.nih.gov/33037410/
7. Weirich, Sara, Khella, Mina S, Jeltsch, Albert. 2021. Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases. In Life (Basel, Switzerland), 11, . doi:10.3390/life11070703. https://pubmed.ncbi.nlm.nih.gov/34357075/
8. Li, Chunying, Xie, Qiqi, Ghosh, Sugata, Nephew, Kenneth P, Shen, Jia. 2024. SUV39H1 Preserves Cancer Stem Cell Chromatin State and Properties in Glioblastoma. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.08.15.607856. https://pubmed.ncbi.nlm.nih.gov/39229036/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen